Submit Deal

GENKYOTEX

Summary

Genkyotex is the leading biopharmaceutical company in NOX therapies.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 79 M

Avg. Deal Size£ 79 M

Market Context

Senior Management

Sort

Target: GENKYOTEX

Bidder: CALLIDITAS THERAPEUTICS

14 Service Providers

34 Dealmakers

£ 79 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy